MEITL manifests as a wide variety of gastrointestinal symptoms, ranging from abdominal pain, weight loss, and diarrhea to serious symptoms such as bleeding, perforation, and obstruction; however, no characteristic clinical symptoms have been established for this disease [
6]. Only 10% of affected patients are diagnosed endoscopically, with majority diagnosed through surgery [
7]. As in the present case, MEITL is often discovered accidentally without symptoms or is diagnosed when the disease has already progressed [
4]. Among few papers presenting the endoscopic findings of MEITL, Tian et al [
8]. described this disease as a semicircular shallow ulcer accompanied by numerous fine granules and mucosal thickening. In our patient, ulceration with associated mucosal thickening was also observed. Histomorphologically, neoplastic cells in MEITL are described as small- to medium-sized, monomorphic, and epitheliotropic lymphocytes, with pale cytoplasm and round nuclei [
2]. The cells are CD3
+, CD4
-, CD5
-, CD8
+, CD56
+, CD30
-, MATK
+, EBER
-, and T-cell receptor-gamma delta
+ [
9]. Cytotoxic markers such as TIA-1, granzyme B, and perforin are also present [
9]. Cyclophosphamide-adriamycin-vincristine-prednisone-based chemotherapy, with or without consolidative autologous stem cell transplantation, remains the mainstay of treatment [
3]. In an Asian MEITL series, 72% of patients were treated with chemotherapy, whereas 58% underwent both surgery and chemotherapy [
5]. However, the high rate of treatment discontinuation owing to disease progression or treatment-related adverse events continues to be a major concern in this patient population [
1]. Surgical resection is necessary when symptoms appear, and approximately 50% of patients undergo emergency surgery for intestinal perforation or obstruction [
5,
7]. If intestinal perforation occurs, the prognosis is expected to be worse, as chemotherapy is delayed owing to peritonitis, septic shock, and multiple organ failure [
10]. In the present case, treatment was likely delayed because of intestinal obstruction prior to anticancer therapy, leading to rapid clinical deterioration. Generally, the diagnostic ratio of intestinal T-cell lymphoma (ITCL) by endoscopy, including tissue biopsy, is low [
11] for the following reasons: 1) tissue specimens from endoscopic biopsy are usually not sufficiently large to allow a correct diagnosis; 2) ITCL is primarily located in the submucosa and smooth muscle, and detection of the lesion through the mucosal layer from biopsy specimens is difficult; and 3) the disease can easily be overlooked because of its rarity. Therefore, tissue biopsies of ulcerative gastrointestinal lesions should be performed carefully from the base of the ulcer while considering the possibility of malignant lymphoma [
11]. In this patient, despite a prompt biopsy following the incidental detection of a colonic ulcer and a second endoscopic biopsy performed shortly thereafter, an endoscopic diagnosis could not be achieved. If several deeper biopsies, including those of the submucosa, were performed at the time of the initial endoscopy, the possibility of early diagnosis may have increased. Moreover, although our patient underwent colonoscopy over a short follow-up period, the ulcer showed an atypical clinical course, appearing to improve and form a scar within a short interval. Such a presentation has rarely been reported in the related literature, and we report this case to highlight its unusual endoscopic features. Additionally, owing to this atypical pattern, careful differen-tiation from other diseases, such as benign ulcers or inflammatory bowel disease, is necessary. Our case underscores the importance of early diagnosis of MEITL, as the rapid progression of the disease can have a fatal consequence. Endoscopists and clinicians need to be vigilant in understanding endoscopic and histological findings to ensure prompt diagnosis and treatment of this aggressive disease.